Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4906 (116th)

Insulin Price Reduction Act

referredUnited States· United States Congress· EN

Introduced

29 October 2019

Last action

30 October 2019 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. DeGette, Diana [D-CO-1], Rep. Reed, Tom [R-NY-23], Colin Allred, Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Garcia, Sylvia R. [D-TX-29], Sen. Slotkin, Elissa [D-MI], Rep. Hastings, Alcee L. [D-FL-20], Rep. Davids, Sharice [D-KS-3], Rep. Stevens, Haley M. [D-MI-11], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. McAdams, Ben [D-UT-4], Rep. Wild, Susan [D-PA-7], Rep. Harder, Josh [D-CA-9], Rep. Kuster, Ann M. [D-NH-2], Rep. Maloney, Sean Patrick [D-NY-18], Rep. Bishop, Sanford D. [D-GA-2], Rep. Waters, Maxine [D-CA-43], Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Rose, Max [D-NY-11], Rep. Price, David E. [D-NC-4], Rep. Dingell, Debbie [D-MI-6], Rep. Schrier, Kim [D-WA-8], Rep. McCollum, Betty [D-MN-4], Rep. Axne, Cynthia [D-IA-3], Rep. Boyle, Brendan F. [D-PA-2], Rep. Cicilline, David N. [D-RI-1], Rep. Clay, Wm. Lacy [D-MO-1], Rep. Connolly, Gerald E. [D-VA-11], Rep. Davis, Danny K. [D-IL-7], Rep. Deutch, Theodore E. [D-FL-22], Rep. Higgins, Brian [D-NY-26], Rep. Kaptur, Marcy [D-OH-9], Rep. Lowey, Nita M. [D-NY-17], Rep. Soto, Darren [D-FL-9], Rep. Perlmutter, Ed [D-CO-7], Rep. Pingree, Chellie [D-ME-1], Rep. Lee, Susie [D-NV-3], Rep. Aguilar, Pete [D-CA-33], Rep. Ruppersberger, C. A. Dutch [D-MD-2], Rep. Hayes, Jahana [D-CT-5], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Castro, Joaquin [D-TX-20], Rep. Kelly, Mike [R-PA-16], Michael San Nicolas, Rep. Craig, Angie [D-MN-2], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Larson, John B. [D-CT-1], Rep. García, Jesús G. "Chuy" [D-IL-4]

Subjects

Healthcare, Taxation

Source updated

5 December 2025

Healthcare · Taxation

Official sourceDownload fileView documentsShare

Summary

Insulin Price Reduction Act This bill prohibits health insurance plan issuers and pharmacy benefits managers (PBMs) from receiving rebates or discounts for insulin from manufacturers who certify that its current insulin list price has been reduced to an amount no greater than what the list price was for the same insulin on July 1, 2006. This restriction does not apply to discounts provided to insurance plan holders at retail sale or to flat-rate fees for service paid to PBMs. Further, insurance plans are prohibited from applying a deductible to insulin that has received such price certification. A manufacturer may certify insulin prices by submitting to the Department of Health and Human Services data about the list price of any insulin the manufacturer has produced since January 1, 2000, and by setting the current list price for an insulin product at the 2006 rate. To remain certified, a manufacturer may not increase the list price of insulin by more than the annual increase in the medical care consumer price index. A manufacturer may certify the price of an insulin product for which it did not have a list price in 2006 by reducing the list price of such insulin to the weighted average list price in 2006 of specified insulin categories. This bill also applies to Medicare prescription drug benefits. The bill sets the rebate for insulin under Medicaid based on the average manufacturer price of insulin during the last fiscal quarter of 2019, increasing by the medical care consumer price index thereafter.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 29 October 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 29 October 2019

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 29 October 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 30 October 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 29 October 2019

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 29 October 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 29 October 2019

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 57 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.